NCS Multistage – Investor Update

Highlights:

Q1 2023 Performance:

• Total revenue of $43.6 million, an 11% increase compared to Q1 2022
• U.S. revenue of $11.3 million; Canadian revenue of $30.7 million; International revenue of $1.6 million
• Cost of sales, excluding depreciation and amortization, of $25.0 million
• S,G&A of $16.2 million, including $0.9 million of non-cash share-based compensation
• Adjusted EBITDA* of $4.9 million, an increase of $2.6 million compared to Q1 2022

Q1 2023 Balance Sheet and Cash Flow:

• March 31 cash balance and total debt of $13.6 million and $8.4 million, respectively
• Net working capital* of $61.7 million and $55.0 million at 3/31/23 and 3/31/22, respectively
• Q1 net capital expenditures of $0.5 million and free cash flow* of $(2.0) million

Q2 2023 Financial Guidance*:

• Total Revenue of $27 – $30 million
• Adjusted EBITDA of $(3) – $(2) million
• Depreciation and amortization expense of $1 million

Full Year 2023 Financial Guidance*:

• Total revenue of $170 – $185 million
• Adjusted EBITDA of $20 – $25 million
• Gross capital expenditures of $3 – $5 million